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A single-nuclei RNA sequencing study of
Mendelian and sporadic AD in the human
brain
Jorge L. Del-Aguila1,2,4, Zeran Li1,2,4, Umber Dube1,2,4, Kathie A. Mihindukulasuriya1,4, John P. Budde1,2,4,
Maria Victoria Fernandez1,2,4, Laura Ibanez1,2,4, Joseph Bradley1,2,4, Fengxian Wang1,2,4, Kristy Bergmann1,2,
Richard Davenport1,2, John C. Morris2,3,5, David M. Holtzman2,3,5, Richard J. Perrin2,3,6, Bruno A. Benitez1,4,
Joseph Dougherty7, Carlos Cruchaga1,2,3,4,7* and Oscar Harari1,2,3,4,7*

Abstract
Background: Alzheimer’s disease (AD) is the most common form of dementia. This neurodegenerative disorder is
associated with neuronal death and gliosis heavily impacting the cerebral cortex. AD has a substantial but
heterogeneous genetic component, presenting both Mendelian and complex genetic architectures. Using bulk
RNA-seq from the parietal lobes and deconvolution methods, we previously reported that brains exhibiting
different AD genetic architecture exhibit different cellular proportions. Here, we sought to directly investigate AD
brain changes in cell proportion and gene expression using single-cell resolution.
Methods: We generated unsorted single-nuclei RNA sequencing data from brain tissue. We leveraged the tissue
donated from a carrier of a Mendelian genetic mutation, PSEN1 p.A79V, and two family members who suffer from
sporadic AD, but do not carry any autosomal mutations. We evaluated alternative alignment approaches to
maximize the titer of reads, genes, and cells with high quality. In addition, we employed distinct clustering
strategies to determine the best approach to identify cell clusters that reveal neuronal and glial cell types and avoid
artifacts such as sample and batch effects. We propose an approach to cluster cells that reduces biases and enable
further analyses.
Results: We identified distinct types of neurons, both excitatory and inhibitory, and glial cells, including astrocytes,
oligodendrocytes, and microglia, among others. In particular, we identified a reduced proportion of excitatory
neurons in the Mendelian mutation carrier, but a similar distribution of inhibitory neurons. Furthermore, we
investigated whether single-nuclei RNA-seq from the human brains recapitulate the expression profile of diseaseassociated microglia (DAM) discovered in mouse models. We also determined that when analyzing human singlenuclei data, it is critical to control for biases introduced by donor-specific expression profiles.
Conclusion: We propose a collection of best practices to generate a highly detailed molecular cell atlas of highly
informative frozen tissue stored in brain banks. Importantly, we have developed a new web application to make
this unique single-nuclei molecular atlas publicly available.
Keywords: PSEN1, Single-nuclei RNA-seq, Alzheimer’s disease, Web-based brain molecular atlas
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Background
Alzheimer’s disease (AD) is a neurodegenerative disorder
characterized by the presence of amyloid Aβ plaques
and neurofibrillary tangles (hyperphosphorylated tau deposits) in the brain [1]. AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.
AD has a substantial but heterogeneous genetic component. While carriers of mutations in the amyloid-beta
precursor protein (APP) and Presenilin genes (PSEN1
and PSEN2) [2, 3] show Mendelian inheritance patterns,
the majority of the AD cases (90–95%) present a complex genetic architecture (sporadic AD), with many genetic factors contributing to risk. Recently, we studied the
cellular population structure of AD brains of carriers of
Mendelian mutations in APP, PSEN1, and PSEN2, and
sporadic ADs and compared them to neuropathologyfree controls [4]. To do so, we generated bulk RNA-seq
from the parietal lobe and analyzed it using an optimized digital deconvolution method [4] to infer broad
proportions of neurons, astrocytes, oligodendrocytes,
and microglia. Importantly, we identified that the brains
of the carriers of Mendelian mutations have a specific
distribution of neurons that differs from that of sporadic
AD [4]. However, bulk RNA-seq and deconvolution approaches do not provide a detailed context of expression
profiles at the cellular level, which hampers the identification of which neuronal subtypes [5] are the most vulnerable to the AD pathogenesis.
Single-cell RNA-seq (scRNA-seq) provides the opportunity to generate the detailed transcriptomic cell profiling required to address the drawbacks of bulk RNA-seq
[6–8]. However, performing scRNA-seq requires cell resuspension, and library preparation needs to be done
from fresh tissue. This requirement prohibits the study
of highly informative frozen human brain tissue stored
in brain banks. Single-nuclei RNA-seq (snuclRNA-seq)
is an alternative to this methodology. Studies of mouse
neural progenitor cells show that only small differences
are present between total cellular and nuclear RNA profiles [9]. We sought to investigate the feasibility of generating and employing unsorted snuclRNA-seq to analyze
banked brains from related individuals, which exhibit
Mendelian or sporadic genetic architectures of AD. We
hypothesize that cell-type expression profiling data from
these brains will provide a unique resource to (i) obtain
a highly detailed map of cell composition in human
brains of AD, (ii) determine cellular population structure
changes in common and specific to Mendelian and sporadic AD, and (iii) characterize transcriptomic profile alterations in AD within each defined cell type.
We discovered that analyzing snuclRNA-seq from the
human brains has its own challenges, as most of the
current tools and pipelines are set up to analyze scRNAseq obtained from fresh tissue. When applying these to
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snculRNA-seq, we encountered artifacts and biases that
constrained downstream analyses. Thus, we propose an
approach to extend scRNA-seq analyzing methodology
to snuclRNA-seq to identify clusters of nuclei that show
trustworthy expression profiles, and which resemble distinct subtypes of neurons and glial cells, including oligodendrocytes, microglia, and astrocytes, among others. In
addition, these clusters have an even (fair) representation
of the nuclei from all of the donors, a property required
by many single-nuclei downstream analyses. We then
employed this approach to process the snuclRNA-seq
from human frozen brains and analyze the distribution
of neuronal subtypes in the brains with Mendelian and
complex genetic architectures of AD.
Recently, a novel type of microglia has been proposed
to be associated with neurodegeneration [10]. The disease-associated microglia (DAM) was identified generating scRNA-seq from sorted microglial cells from mouse
models [10] and then validated using immunohistochemical staining of human brain tissue to demonstrate
the colocalization of Aβ particles with a protein marker
of DAM [10]. Here, we analyze whether the expression
profile of human microglia detected by snuclRNA-seq
recapitulate the DAM expression signature detected in
mouse models.
Finally, our findings indicate that snuclRNA-seq provides a valuable resource that can improve our understanding of the sequence of regulatory events that
control cell fate leading to AD. Therefore, we are making available the nucleus-specific expression profile of
the brains we analyzed through an interactive web-based
application (http://ngi.pub/snuclRNA-seq) to provide
full access to the research community to this resource.
This is the first single-nuclei molecular atlas of AD
brains carrying pathological mutations in PSEN1 and related sporadic AD. We hope that this high-quality data
will help elucidate and validate novel biological insights
into AD and contribute to early diagnosis and therapeutic intervention.

Methods
Samples

The Neuropathology Core of the Knight-Alzheimer’s
Disease Research Center (Knight-ADRC) provided the
parietal lobe tissue from the postmortem brains for each
sample. These samples were obtained with informed
consent for research use and were approved by the institutional review board of Washington University in St.
Louis. AD neuropathological changes were assessed according to the criteria of the National Institute on
Aging-Alzheimer’s Association (NIA-AA). One AD patient is a carrier of the PSEN1 p.A79V pathogenic mutation, while the two relatives do not carry any autosomal
mutations (sporadic AD). The three donors are females

Del-Aguila et al. Alzheimer's Research & Therapy

(2019) 11:71

with European-American ancestry. Additional information including the clinical dementia rating (CDR), APOE
genotype, postmortem interval (PMI), age at onset, and
age at death are detailed in Table 1.

Nuclei extraction and library preparation

From the fresh frozen human parietal lobes, approximately 500 mg of tissue was cut and weighed on dry
ice using sterile disposable scalpels. The parietal tissue was homogenized in ice-cold homogenization buffer (0.25 M sucrose, 150 mM KCl, 5 mM MgCl2, 20
mM Tricine-KOH pH 7.8, 0.15 mM spermine, 0.5 mM
spermidine, EDTA-free protease inhibitor, and recombinant RNase inhibitors) with a glass-on-glass dounce
homogenizer, 10 strokes with the A pestle, followed
by 10 strokes of the B pestle. Homogenates were centrifuged for 5 min at 500×g, at 4 °C, to pellet the nuclear fraction. The nuclear fraction was mixed with
an equal volume of 50% iodixanol and added on top
of a 35% iodixanol solution for 30 min at 10,000×g, at
4 °C. After the removal of the myelin layer from the
top of the gradient, the nuclei were collected from
the 30–35% iodixanol interface. The nuclei were resuspended in nuclei wash and resuspension buffer
(1.0% bovine serum albumin and recombinant RNase
inhibitors in phosphate-buffered saline) and pelleted
for 5 min at 500 × Gs, 4 °C. The nuclei were passed
through a 40-μM cell strainer to remove cell debris and
large clumps. Nuclei concentration was manually determined using DAPI counterstaining and hemocytometer.
Nuclei concentration was adjusted to 1200 nuclei/μL and
followed immediately by the 10X Genomics® Single Cell
Protocol. We generated snuclRNA-seq libraries using the
10X Chromium V(D)J 5` chemistry for 10,000 cells per
sample and sequenced 50,000 reads per cell from the 3
frozen human parietal lobes.
Table 1 Demographic characteristics of the samples
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Sequencing alignment and data for secondary analysis

The CellRanger (v2.1.1 10XGenomics) software was
employed to align the sequences and quantify gene expression. By default, this software quantifies the expression for mature messenger RNA (mRNA) by counting
reads aligned to exons as annotated in the human genome build GRCh38. However, the snuclRNA-seq profiles nuclear precursor mRNA (pre-mRNA), which
includes transcripts that have not completed splicing to
remove introns. To capture all the information in the
pre-mRNA, we aligned the reads to a custom “premRNA” reference that was generated as described by
10X Genomics technical manual [6]. In this way, the intronic reads from pre-mRNA are included in the final
gene expression counts. We aligned and quantified the
gene expression using both mature and pre-mRNA references, and these reads were further cleaned QCed
and compared.
Single-nuclei RNA-seq cleaning

The gene expression matrices from all samples were
combined in R independently for further processing
using the Seurat (version 2.20, 2.30) pipeline. We processed the gene expression quantified for the pre-mRNA
and mRNA references in parallel. We removed most of
the mitochondrial genes (< 0.1%) and then kept the
genes expressed in three or more cells. We discarded
cells with less than 1800 or more than 8000 genes
expressed. To exclude multiplets, when a single droplet
includes two or more nuclei, the top 0.5% of the distribution of nUMI (total number of unique molecular
identifiers detected in each cell) were removed. We also
studied whether the number of genes expressed per nuclei followed a multi-modal distribution, under the assumption that glial cells could express a lower number
of genes than neurons [11]. This analysis was performed
by the R package mixtools [12]. We normalized the data
employing the LogNormalize function, which normalizes
the gene expression measurements for each cell by the
total expression; scales by a factor equal to the median
counts of all genes and log-transforms the expression.
Data regression was performed using the ScaleData
function with nUMI, percent mitochondrial reads, and
sample origin as confounding factors.

Sample1

Sample2

Sample3

PSEN1 mutation

Non-carrier

Non-carrier

Ala79Val

Gender

Female

Female

Female

Age on set (years)

87

81

76

Age at death (years)

89

82

89

CDR

1

3

3

Selection of genes for cell clustering

APOE

ɛ3/ɛ4

ɛ3/ɛ3

ɛ3/ɛ4

PMI

9

17.2

8

The snuclRNA-seq expression data is highly dimensional,
as thousands of nuclei are ascertained transcriptome-wide
for each brain. However, as single-cell methods are lossy,
the quantification of snuclRNA-seq produces sparse data
matrices, and the expression of each gene is not detected
for each nucleus. The structure of the data complicates
the clustering of the nuclei into distinct cell types, and
conventional similarity distances, such as Euclidean

Freezer time& (years)

11

22

24

Braak amyloid beta*

C

NA

C

AD

AD

AD

Neuropathology&
&

Freezer time: the years that elapsed since the death to snuclRNA-seq library
preparation. *C: Stage C (deposition of amyloid in isocortical areas). AD
Alzheimer’s disease, NA no data
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distance, have been claimed to be less reliable as the dimensions of the feature space increase [13]. However, only
hundreds of genes are required to discriminate cell types.
The selection of a representative set of genes to cluster
the nuclei is a key step in the processing of data, in which
only the informative genes are filtered, in such a way that
clustering of nuclei is computationally feasible. Given the
importance of this processing step, we evaluated alternative approaches, described below.

Sample1, Sample2, and Sample3, respectively. Then, we
identified the common set of genes that were highly
variable among the samples using the R function intersection (N = 1434). These common genes were used to
calculate 100 PCs from all of the samples (Seurat package). We selected the number of PCs using the same
methodology described in the “Classic Gene Set from
pooled subjects” section and employed the first 25 PCs
for downstream analysis.

Classic Gene Set from pooled subjects

Cell/nuclei clustering

The Classic Gene Set (CGS) method is the approach
most commonly employed to select the most variable
genes in scRNA-seq studies [14, 15]. The Seurat FindVariableGenes function performs this selection. We executed this method by using the default values and
cutoffs (x.low.cutoff = 0.0125, x.high.cutoff = 3, y.cutoff =
0.8) and selected the most variable genes from the single
nuclei expression from the three brains. We obtained
2360 genes that were used to calculate 100 principal
components (PCs). Then, we identified the optimal
number of PCs for downstream analysis using heuristics,
PC elbow plot, and JackStraw statistical tests. The JackStraw function randomly permutes a subset of data and
calculates projected PC scores for these genes. This analysis indicated that the first 65 PCs were sufficient for
clustering the nuclei.

The goal of this process is to group the nuclei based on
the similarities between their expression profiles. We
used the Seurat function FindClusters to identify the
clusters with a resolution parameter 0.6 and employed
the TSNEPlot function to generate a visual representation of the clusters using T-distributed Stochastic Neighbor Embedding (tSNE). In addition, we corrected for
dropout events that lead to an exceedingly sparse depiction of the single-cell transcriptome. Instead of removing
genes containing missing values, which restricts the analysis to only highly expressed genes, we imputed missing
gene expression values using scImpute [20]. After imputing gene expression, we clustered the nuclei again. Finally, we learned similarity relationships among the
expression profile of the cells included in the clusters by
using the function BuildClusterTree.

Hicat Gene Markers

Coincidence analysis

This method proposed by Taasic et al. [16] employs
known gene markers of cell types to generate an initial
partition of the cells into broad cell clusters. Later on,
this initial partition can be subclustered to identify cell
subtypes. For our analysis, we employed all the nuclei
that passed QC, using 118 known gene markers, that we
collected from the literature (Additional file 1: Table S1)
[5, 11, 17–19]. We calculated the first 100 PCs from the
expression of these marker genes, as quantified using
the pre-mRNA annotation (Seurat software). We selected the number of PCs using the same methodology
as described in the “Classic Gene Set from pooled subjects” section and selected the first 55 PCs for downstream analysis.

To compare the results of distinct clustering approaches
and identify whether three different approaches were
producing (dis)similar clusters, we implemented a coincidence analysis. We performed an exhaustive comparison of each cluster identified by one processing and
clustering approach to all of the clusters identified by a
second approach. In this way, we can determine how the
cells are reorganized among different clusters or, in contrast, to identify if cells are grouped coincidently together by distinct approaches. To do so, we calculate the
normalized pointwise mutual information (pmi):

Consensus Gene Set

The approach we propose, the Consensus Gene Set
(ConGen), controls for biases and obtains clusters with
even representation of all samples. We applied the Seurat FindVariableGenes with default selections and cutoffs
values (x.low.cutoff = 0.0125, x.high.cutoff = 3, y.cutoff =
0.8) for each library sample and identified a set of highly
variable genes for each brain sample whose expression
was quantified using pre-mRNA annotation. The number of highly variable genes is 2447, 2354, and 1972 for

pmiðx; yÞ ¼ log

pðx; yÞ
pðxÞpðyÞ

which quantifies the discrepancy between the probability
of joint distribution of two clusters and their individual
distributions. In addition, we calculated the Jaccard
index, or similarity coefficient, which is defined as:
Jaccardðx; yÞ ¼

j x∩y j
j x∪y j

The Jaccard index evaluates the extent of the intersection of the nuclei in common between two clusters, corrected by the extent of the union of the nuclei assigned
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to the two clusters. To provide a global overview of the
clusters’ coincidence, we plotted the pointwise comparisons and we represented the pmi by color and the Jaccard index by the size of the point (Online Resource:
https://github.com/NeuroGenomicsAndInformatics/
snuclRNA-seq/tree/master/tools).
Entropy as a measure to evaluate donor evenness and
biases in clustered nuclei

Having an even representation of the nuclei from distinct samples in a cluster is critical to perform unbiased
comparisons. Otherwise, clusters of nuclei with overrepresentation or underrepresentation of samples precludes
many downstream analyses. We employed Shannon’s information theory entropy [21] as a quantitative measure
to evaluate how even or biased the distribution of samples among the nuclei of any given cluster is. Specifically, the entropy of a cluster is calculated as:
X
^ ¼−
H
pðiÞ log2 ðpðiÞÞ
where p(i) is the probability of the nuclei belonging to
the subject i. The entropy tends to 0 when all of the cells
from a cluster belong to a single subject and is maximized when the distribution of subjects is perfectly uniform which is 1.58 for three samples (Online Resources:
https://github.com/NeuroGenomicsAndInformatics/
snuclRNA-seq/tree/master/tools).
Cluster annotation

We determined the brain cell types in each of the cluster
by evaluating the expression of maker genes for neurons,
astrocytes, oligodendrocytes, microglia, oligodendrocyte
precursor cells, and endothelial cells, usually employed in
the literature [5, 11, 17–19] (Additional file 1: Table S2
and Table S3). We used the DotPlot function from the
Seurat package to visualize the average expression of
genes related to specific cell types. To determine the homogeny of brain samples analyzed, we also evaluated the expression of marker genes tagging distinct pyramidal layers
for the excitatory neurons. We also looked for excitatory
and inhibitory neurons [5].
Pseudo-temporal trajectories of microglia expression
profiles

The gene expression for the microglia was analyzed
using the R package TSCAN (version 1.7.0) to infer a
pseudo-temporal path [22]. This method orders cells
based on the transition of their transcriptomes, by initially clustering cells then identifying similarity relationships among the clusters, inferring a minimal spanning
tree (MST), projecting cells onto tree edges and finally
using generalized additive models to ascertain the functional relationship between the pseudo-time and gene
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expression. The raw expression data from microglial
cells was loaded and pre-processed (TSCAN function
preprocess) using default parameters. We then executed
the exprmclust function with default parameters to learn
the optimal number of clusters for microglia. Then, we
employed the tscan function in order to identify pseudotime trajectories of the cells. Finally, we used the processed expression data and the pseudo-order to identify
the genes associated with this ordering, using the difftest
function.
Single-nuclei gene expression browser

We developed a web application to provide public access to
the single-nuclei transcriptomic atlas. All of the snuclRNAseq data that we generated and processed can be queried
and visualized using a custom browser that we have developed using the R Shiny framework. This browser provides
an input panel to query individual genes and additional parameters to customize the visualization. For each gene, the
browser provides graphical information organized in three
panels: (i) The tSNSE projection of the nuclei is represented
and colored by the clusters. We identified and annotated
these clusters using Seurat TSNEPlot function. (ii) A gene
expression level for each nucleus is graphically represented
using the same tSNE representation. The nuclei are colored
according to the expression level of the queried gene. We
represent the nuclei highly expressing the target gene in purple and the nuclei with lower expression in gray (Seurat FeaturePlot function). (iii) We show the cell type-specific
differential expression (log fold change, p value, and adjusted
p value) of queried genes for neurons, astrocytes, microglia,
oligodendrocyte, oligodendrocyte precursor cells (OPC), and
endothelial cells that was pre-computed beforehand. We first
grouped the clusters by cell type (Seurat BuildClusterTree
function). As a result, we obtained a unique cluster that includes all of the neurons, while conserving clusters for each
of the remaining cell types. Thus, the nuclei are partitioned
into a total of six clusters. Then, we calculated the differential
expression for each gene among these six clusters using the
Seurat FindMarkers function. The statistical significance was
calculated using the non-parametric Wilcoxon rank-sum test
to determine those genes that had a log fold change > 0.01.
In this way, we generated a broader comparison of the
transcriptome. The adjusted p value is adjusted using a
Bonferroni multiple test correction. All of the source code
for the snuclRNA-seq explorer and the precomputation of
the differential expression is available in the GitHub repository (https://github.com/NeuroGenomicsAndInformatics/
snuclRNA-seq/).
Bulk RNA-seq processing

In parallel, we generated bulk RNA-seq data for the
three brains that we analyzed and followed the same QC
and processing as we reported previously [4]. These data
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were mapped to mRNA reference for the human genome build GRCh38.
Ascertaining snuclRNA-seq quality

To control for the quality of the processed transcriptomic snuclRNA-seq, we compared the gene expression
values from both alignments for each subject and, as a
group, to their gene expression values from their bulk
RNA-seq.

Results
Study design

We collected snuclRNA-seq data from three EuropeanAmerican female donors. We employed two different
references for alignment, pre-mRNA and mRNA, to
quantify the gene expression for each sample donor.
Each sample was accompanied by the processing of a
matching bulk RNA-seq sample using mRNA as a reference. These steps allowed us to estimate how well
snuclRNA-seq data can recapitulate the RNA-seq results
from bulk samples. The gene expression matrices from
all samples were combined for further processing. Three
different approaches were tested to select the variable
genes that were used to determine the principal components for the nuclei clustering. We processed each approach in parallel. We tested the evenness of each
cluster for each approach as well as critical parameters
such as resolution and coincident analysis. The approach
with the best results was then imputed and used for further analyses including the pseudo-time trajectories of
the cells and disease-associated microglia association. Finally, we prepared a browser using the R Shiny framework to visualize the snuclRNA-seq data that we
produced.
Clinical and demographic characteristics

The complexity and uniqueness of the cell types in the
different regions and layers in the human brain were
previously described [5, 23–28]; however, the sample
quality is diminished in postmortem samples. To obtain
highly detailed maps of cell composition in AD brains
with distinct genetic architecture and to characterize
their transcriptomic profiles at a cellular level, we analyzed snuclRNA-seq from the parietal lobe [29–32], for
three subjects (Additional file 1: Figure S1). All three donors were European-American females, with an age of
death ranging from 82 to 89 years and were members of
the same family. One of the donors, Sample3, was a carrier of the PSEN1 p.A79V (ADAD) while the other two
donors, Sample1 and Sample2, presented a complex
genetic architecture of AD. Neuropathology showed definitive AD for all the samples. The Braak amyloid stage
for Sample1 and Sample3 is C (deposition of amyloid in
isocortical areas); no data was recorded for Sample2.
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Sample collection or postmortem interval (PMI) ranged
between 8 and 17.2 h (Table 1). As previously reported
[5, 33, 34], we did not observe any effect of the PMI of
the samples and quality of snuclRNA-seq. Neither did
we observe any effect of the lapse of time the samples
were frozen until we generated the data (freezer time)
and quality of the data.
Generation and quality evaluation of human brain tissue
single-nuclei RNA-seq

We generated snuclRNA-seq libraries using the 10× Chromium for 10,000 cells per sample and sequenced 50,000
reads per cell from 3 frozen human parietal lobes. We
employed 2 different alignment libraries for the annotation of the genome, pre-mRNA and mRNA, and quantified gene expression using both (see the “Methods”
section). We observed that when we aligned the reads to
pre-mRNA, the number of reads, genes, and cells increases significantly. For example, when using pre-mRNA
as a reference, we observed a 36% increase in the number
of nuclei (26,331 vs 19,302; χ2 test, p ≤ 2.2 × 10−16, Table 2),
without affecting the number of identified transcripts (28,
428 vs 25,465 counts). We also observed a 118.8% increase
in the number of the median UMI counts per nuclei (t
test, p = 1.5 × 10−2) and a 45.1% for the median genes per
nuclei (t test, p = 5.0 × 10−3).
To further evaluate the quality of snuclRNA-seq data,
we compared the gene expression values from the two
alignments “pre-mRNA” and “mRNA” in snuclRNA-seq
to their gene expression values from their parallel bulk
RNA-seq aligned to the mRNA reference data (Table 3).
We observed a Pearson correlation of r2 = 91% between
snuclRNA-seq with mRNA reference and bulk RNA-seq
(Fig. 1a). On the other hand, the Pearson correlation of
snuclRNA-seq with pre-mRNA reference against bulk
RNA-seq was r2 = 86% (Fig. 1B). These results may suggest that aligning to mRNA is a better approach, but it
is important to note that the alignment to pre-mRNA
increased the number of nuclei, median UMI counts per
Table 2 Summary statistics after quality control
Sample1 Sample2 Sample3 All
Alignment to precursor RNA (pre-RNA)
Number of nuclei

5663

7147

13,521

26,331

Median UMI counts per nuclei 11,560

14,444

6543

9262

Median genes per nuclei

4006

5064

2852

3642

Total genes detected

28,428

28,428

28,428

28,428

4493

7197

7612

19,302

Median UMI counts per nuclei 3960

7162

2464

4234

Alignment to mature-RNA
Number of nuclei

Median genes per nuclei

2355

3851

1579

2510

Total genes detected

25,469

25,469

25,469

25,469
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Table 3 Correlation analysis between bulk RNA-seq and
snuclRNA-seq after QC
Reference alignment
snRNA-seq

Bulk RNA-seq mature-RNA

Pre-RNA

0.86

Mature RNA

0.91

All values are Pearson coefficient

nuclei, and median genes per nuclei significantly. In
addition, the correlation we identified for the pre-mRNA
is in line with the values previously reported for singlecell RNA-seq [35].
These results indicated that the inclusion of introns for
quantifying the gene expression of snuclRNA-seq data provides a better description of the nuclei-specific expression
profile, while conserving a correlation to the expression of
bulk RNA-seq, which validates the accuracy of this data.
CGS approaches to cluster single nuclei from human
postmortem brains

We initially sought to identify different cell types in the
brain samples by a CGS approach that performs an unsupervised graph-based clustering [36] to identify the
groups of cells with similar expression profiles. This approach detected 25 clusters using 2360 highly variable
genes using the default resolution of 0.6 (Additional file 1:
Table S4, Fig. 2a). The clusters were annotated in six cell
types (Fig. 2b, Additional file 1: Figure S2); however, we
noticed that many clusters included cells that were not
evenly distributed among the three donors, but instead

Page 7 of 16

showed an overrepresentation or an underrepresentation
of donors. Specifically, Sample2 is overrepresented in
cluster 0 and underrepresented in clusters 2 and 3. Similarly, Sample3 is overrepresented in clusters 7 and 10
(Additional file 1: Table S4, Fig. 2b). We employed Shannon’s entropy to formally quantify the evenness of cell
distribution among donors (see the “Methods” section).
This a metric that is maximized when the probability
distribution is uniform. For the three brains we analyzed,
its values ranged from 0 to 1.58. An even distribution of
the three brain samples in a cluster would result in entropy > 1.2. Lower values to this cutoff would be expected for a cluster with a 65% of overrepresentation of
cells from a single donor or an underrepresentation of
10%. We observed that for clusters 0, 2, 3, 7, and 10, the
entropy < 1.2 (Additional file 1: Table S4). Note that
these clusters that exhibit uneven distribution of subjects included 9781 nuclei, which represents 37.1% of
the nuclei that passed QC. These clusters would not
allow us to perform downstream comparisons on a relatively large proportion of the cells we sequenced, as
many of these analyses require fair sampling of cells
from the distinct donors.
We observed that generating a distinct number of clusters (by sampling the parameter resolution with values between 0.2 and 1.2) conserved the overall (nested) structure
of the clusters. Higher resolution values tended to partition
specific clusters, although cells were not reorganized in
clusters with an even distribution of samples. When we

Fig. 1 Correlation between bulk RNA-seq and single-nuclei RNA-seq aligned using the pre-mRNA and mRNA annotation references. Along the Xaxis, we show the gene expression values obtained from the bulk RNA-seq, and along the Y-axis, the single-nuclei expression, which was
analyzed as bulk RNA-seq. a Bulk RNA-seq vs snuclRNA-seq aligned with mRNA (see the “Methods” section). b Bulk RNA-seq vs snuclRNA-seq
aligned with pre-mRNA
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Fig. 2 TSNE plots for the CGS dimensional reduction approach. TSNE plots depicting 26,331 nuclei. a The nuclei are colored to represent the 25
CGS clusters. b The clusters are annotated to represent the cell types (neuron, ologodendrocytes, astrocytes, microglia, OPC, and endothelial)

employed lower resolution values (e.g., 0.2), the clusters
started to show higher entropy values, as they grouped cells
from all of the three donors. However, these clusters did
not present cell type-specific expression profiles. These results indicate that when analyzing snuclRNA-seq from human-related brains, this approach produces some biases
that constrain the comparisons for a large number of cells.
This bias could be addressed by the reduction of the resolution in the analysis, but the expression profile for these
new clusters is not specific.
The Hicat Gene Markers approach does not generate a
trustworthy cell type-specific expression profile

Next, we evaluated whether clustering nuclei based on
genes usually employed as cell type marker would produce
cell type-specific clusters. This approach, called “Hicat
Gene Markers” [16], has been previously employed to
analyze cell sorting (FACS) neurons. Using cell type
markers (see the “Methods” section; Additional file 1: Table
S1), we clustered the nuclei into 23 bins (resolution 0.6
Additional file 1: Figure S3). We observed that the nuclei
were better distributed among the samples, and the entropy
values were closer to 1.58 (Additional file 1: Table S5)
which is the maximum value that indicates perfectly even
distribution. However, annotation of the clusters indicated
that this method is not grouping homogenous cell types, as
these clusters did not present cell type-specific distinguishing expression profiles. Only two clusters were clearly

annotated:
oligodendrocytes
and
astrocytes
(Additional file 1: Figure S3). These results suggest that the
expression of these markers, as captured by snuclRNA-seq,
is not sufficient to cluster the nuclei by cell type.
The Consensus Gene Set generates clusters that show cell
type-specific expression profiles

Finally, we envisioned an approach to generate data-driven
clusters while avoiding biases introduced by overrepresentation and underrepresentation of donors in individual clusters. We explored whether the employment of common
genes that are highly variable for each of the three donors
would produce viable nuclei clusters (ConGen Methods).
We detected 1434 highly variable genes that we used to
cluster the nuclei and identified 14 bins (resolution 0.6).
The nuclei in each of the clusters were evenly distributed
among the three samples with overall high entropy values
(Additional file 1: Table S6), and the expression profiles
were specific enough to distinguish distinct cell types and
subtypes (Additional file 1: Figure S6).
Based on these promising results, we generated gene
expression imputed data to reduce the possible technical
zeros (dropouts). From this new data, we identified 13
clusters (resolution 0.6, see Table 4). The gene expression patterns specific to cell type clusters were visualized
using tSNE plot and DotPlot to represent the expression
of gene markers of brain cell types (Fig. 3, Fig. 4). A
coincidence analysis identified a broad similarity
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Table 4 Number of cells for each subject in each cluster using
imputed Consensus Gene Set data
Entropy*
Subject

Sample1

Sample2

Sample3

Number of total cells

5663

7147

13,521

Cluster 0

17.36%

27.16%

18.76%

1.56

Cluster 1

18.68%

17.01%

9.99%

1.54

Cluster 2

9.27%

11.70%

10.69%

1.58

Cluster 3

8.83%

3.86%

14.28%

1.41

Cluster 4

9.34%

7.51%

8.65%

1.58

Cluster 5

10.10%

7.43%

6.96%

1.56

Cluster 6

7.77%

8.17%

6.69%

1.58

Cluster 7

6.29%

6.95%

7.49%

1.58

Cluster 8

6.20%

6.91%

3.78%

1.54

Cluster 9

1.08%

0.74%

7.66%

0.89

Cluster 10

2.95%

1.53%

1.96%

1.53

Cluster 11

0.71%

0.53%

1.52%

1.43

Cluster 12

1.32%

0.14%

1.38%

1.23

Cluster 13

0.11%

0.35%

0.18%

1.42

*Entropy values low < 1.2 values indicates uneven sample representation in
the cluster
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between the clusters generated from the gene expression
imputed data and the non-imputed data (Additional file 1:
Figure S4). All of the clusters in the non-imputed data
were also identified when we re-analyzed the imputed
data, with the exception of two neuronal clusters (7 and
10) that were merged into a single cluster (cluster 6)
after gene expression imputation.
Overall, based on the global expression patterns and similarity relationship among the clusters that we inferred (see
the “Methods” section), we were able to classify all the cells
into three major groups, namely neurons (both excitatory
and inhibitory), glial cells (astrocytes, oligodendrocyte, and
OPC), and non-neural (endothelial and microglia) (Fig. 5).
Lake et al. [5] established a series of neural submarkers that
we employed to identify six subclasses of excitatory (Ex)
neurons and two subclasses of inhibitory (In) neurons
(Fig. 6). The inhibitory subgroups were distributed in different cerebral cortex layers (Fig. 7). Inhibitory cell type 6 (In_
6) was located in layer 2. The inhibitory cell type 1 (In_1)
was located between layer 2 and layer 5. In case of the excitatory neurons, we observed that most of the subclasses occupied multiple layers (Fig. 7). In more detail, excitatory
cell type 1 (Ex_1) covered the whole layer 2 while excitatory
cell type 2 (Ex_2) from layer 2 to layer 4. Excitatory cell
type 4 (Ex_4), excitatory cell type 5 (Ex_5), and excitatory
cell type 6 (Ex_6) spread among layers 4 to 6. Finally, excitatory cell type 8 (Ex_8) covered layers 5 to 6.

Fig. 3 TSNE plots for Consensus Gene Set dimensional reduction approach. TSNE plots depicting 26,331 cells in 14 annotated clusters: Cluster0Ex_1, Cluster1-Ex_2, Cluster3-Ex_4, Cluster2-Ex_5, Cluster8-Ex_6, Cluster4-Ex_7, Cluster10-Ex_8, Cluster6-In_1, Cluster7-In_6, Cluster5Oligodendrocytes, Cluster9-Astrocytes, Cluster11-Microglia, Cluster12-OPC, and Cluster13-Endothelial. In, inhibitory neuron; Ex, excitatory neuron
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Fig. 4 DotPlot depicting the expression of marker genes selected by the literature for the ConGen approach (see Additional file 1: Table S2 and
Table S3). This graphical approach allows us to annotate the clusters that were obtained by after the selection of the 1434 common genes

All of the clusters, except cluster 9 (Astrocytes), showed
an entropy > 1.2 which indicates an even distribution of the
nuclei among the samples. Sample3 is overrepresented in
cluster 9, as 90% of the cells are from this donor (entropy =
0.89; Additional file 1: Figure S6), but no additional clusters
included astrocytes for the other two samples. We evaluated

whether our stringent QC process would remove astrocytes
for Sample1 and Sample2 and introduce a bias in our data.
To do so, we reduced the stringency of the QC parameters
and evaluated whether multi-modal distributions were modeling more accurately the number of genes expressed per nuclei, under the assumption that glial cells may express a

Fig. 5 Dendrogram for Consensus Gene Set clusters. This dendrogram shows the hierarchical relationship between clusters, based on the
Euclidean distance of cluster mean expression. The proximity of that clusters 0, 1, 2, 3, 4, 8, and 10 indicates the same cell type (excitatory
neurons). Inhibitory neurons (clusters 6 and 7) are placed in the same branch as the excitatory neuron. This is another way to confirm the
clustering obtained by TSNE
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Fig. 6 DotPlot depicting the expression of the neuron cell for ConGen approach. Inhibitory neurons are distributed between clusters 6 and 7,
and the excitatory neurons are distributed in clusters 0, 1, 2, 3, 4, and 8 as defined by Lake et al. [5]. In, inhibitory neuron; Ex, excitatory neuron

lower number of genes [11] that would be removed during
the cleaning process. However, using this multi-modal distribution (Additional file 1: Figure S8) for QC and cleaning
did not recover additional astrocytes nuclei. This suggests
that some artifact prevented the efficient capture of astrocytes for these two samples. It has been previously reported
that single-cell dissociation, capture, amplification, and sequencing may distort brain cell abundances [11, 37]. In particular, mouse brain stainings were shown not to be
correlated perfectly with scRNA-seq, suggesting that neurons were overrepresented relative to non-neurons [11, 37].
We performed a coincidence analysis between the ConGen and CGS approaches (Additional file 1: Figure S6) to
qualitatively compare these two approaches. Most of the
neural cells from CGS were reorganized into neuronal clusters using the ConGen. This indicates that ConGen is not
introducing any novel bias or artifact, and the nuclei are
grouped by cell type. Similarly, oligodendrocytes, which
were grouped into two clusters by the CGS approach (clusters 6 and 11), were merged into a single cluster in the
ConGen. The remaining cells were coincidently grouped
into endothelial, oligodendrocyte precursor cell (OPC),
microglia, and astrocyte clusters by both approaches. Overall, these results indicated that the ConGen approach clusters cells in a manner that distinguishes the cell typespecific expression profiles that match those generated by

the CGS approach but reorganized neurons to avoid underrepresentation or overrepresentation of subjects.
Single-nuclei RNA-seq reveals specific differences
between the brain of the PSEN1 p.A79V carrier and the
two family members with sporadic AD

Neuronal cells accounted for 86.7%, 90.8%, and 82.3% of the
cells for Sample1, Sample2, and Sample3, respectively
(Table 5). Once we broke down this number based on the
neural cell subtype, we observed that the inhibitory neurons
for Sample1, Sample2, and Sample3 were 14.1%, 15.2%, and
14.2%, respectively. However, Sample3 (PSEN1 carrier)
showed fewer excitatory neurons (68.1%) compared to Sample1 (72.6%) and Sample2 (75.7%). Overall, this result supports our previous work [4], in which we reported a
decreased neuronal percentage (20%) for carriers of pathological mutations in APP, PSEN1, and PSEN2 and further
suggests that this difference might be specific for excitatory
neurons. In addition, we evaluated whether APOE status affects the clustering of the nuclei, but the data suggest that
APOE has no effect (Additional file 1: Table S7).
Evaluation of disease-associated microglia marker genes
in PSEN p.A79V carrier and sporadic AD

The analyses of sorted microglial cells from mouse
models reported a novel microglia type associated with
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Table 5 Number of cells for each sample in each cell type cluster
Subjects

Sample1

Sample2

Sample3

Number of total cells

5663

7147

13,521

Cluster 6

In_1

Cluster 7

In_6

Cluster 0

Ex_1

Cluster 1

Ex_2

Cluster 3

Ex_4

Cluster 2

Ex_5

Cluster 8

Ex_6

Cluster 4

Ex_7

Cluster 10

Ex_8

Cluster 9

Astrocytes

Cluster 5

Oligodendrocytes

Cluster 12

OPC

Cluster 11

Microglia

Cluster 13

Endothelial

In inhibitory neuron, Ex excitatory neuron

Inhibitory neurons cells

14.06%

15.18%

14.18%

Excitatory neurons cells

72.63%

75.68%

68.12%

1.08%

0.74%

7.66%

10.10%

7.43%

6.96%

1.32%

0.14%

1.38%

Glial cells

Non-neural cells

0.71%

0.53%

1.52%

0.11%

0.35%

0.18%
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neurodegeneration [10] and the role of TREM2 in their
activation program [38]. This previous study performed
immunohistochemical staining of the human brain to
identify the colocalization of Aβ particles with SPP1, a
gene identified as a DAM marker [10]. Since then, much
effort has been invested to identify the expression profile
of DAM in the human brains, including the analyses of
bulk RNA-seq from homogenized human AD brains [38]
and bulk RNA-seq from microglia sorted from ten fresh
autopsy samples [39]. We hypothesize that the snuclRNAseq data captures both the expression profiles of DAM
cells proximal to Aβ plaques and microglial cells distal to
Aβ plaques. We sought to investigate whether the expression profiles of microglial cells we called from the unsorted single-nuclei RNA-seq recapitulate the DAM
marker genes. To do so, we performed an in silico
pseudo-time reconstruction to capture an ordered sequence of the activation and transition to DAM cells from
the transcriptomic profile of microglial cells [22]. From
the 500 genes significantly associated with DAM [10] in
mice AD models, we identified 326 homolog genes in the
human genome. Single-nuclei RNA-seq detected the expression of 92 of these genes in microglial cells (Additional file 1: Table S8). Surprisingly, 79 of these DAM
markers show an expression significantly associated with
the pseudo-time (q value < 0.05). To further investigate
whether any artifact was introduced by the possibly distinct expression profiles of microglia from each donor, we
performed subject-specific analyses. We determined that
only 20 DAM markers were significantly associated with
pseudo-time when we analyzed the PSEN1 carrier (Additional file 1: Table S8). Similarly, 20 and 18 DAM markers
were significantly associated with pseudo-time when we
analyzed the microglial cells from the sporadic AD brains.
Furthermore, five genes were consistently significantly associated with the microglial cells from all three samples,
namely EEF1A1, GLUL, KIAA1217, LDLRAD3, and SPP1.
Curiously, SPP1, also referred as osteopontin, is the only
one of these genes among the top 10 DAM markers identified in mouse AD models and previously employed in
immunohistochemical staining of the human brain [10].
Overall, these results indicate that we did not sequence enough microglial cells to replicate the initial
DAM marker gene findings. However, the analysis of
this microglia suggests promising results. We understand that sorting for glial cells to increase the
microglia nuclei count would be optimally posed to
provide results that are more definitive.
A new web-based tool to explore the molecular atlas of
Mendelian and sporadic AD brains

Our web-based application (http://ngi.pub/snuclRNAseq/) provides interactive access to the single-nuclei
transcriptomic profiles of the three brains we analyzed.

Page 13 of 16

This application is designed to provide a user-friendly
and comprehensive analysis of our data, through any
modern web browser. The site features a graphical representation (tSEN projection) of the nuclei whose clusters are colored by their cell type, while allowing the
selection of the genes with detected expression. For each
gene, a graphical representation of its expression profile
in the distinct cell types is produced, as well as a statistical interpretation of the differential expression among
cell types.
We have regrouped all of the nuclei that were clustered in excitatory and inhibitory clusters that represented neuronal subtypes into a new cluster that
represent all of the neurons (Fig. 5). We have precomputed the statistical significance of the differential expression and also the multiple comparisons correction p
value using Bonferroni multiple test correction. Using
this tool, we validated the marker genes that we utilized
to annotate the clusters (Additional file 1: Table S2) are
significantly overexpressed for the expected cell types.
Furthermore, this tool provides a single-nuclei cell typespecific expression reference that we believe will benefit
additional research projects, including the annotation of
data from other experiments, as well as helping to determine the expression profile of the distinct brain cell
types of candidate genes identified in GWAS and sequencing projects.

Discussion
The complexity and uniqueness of the cell types in the
different regions and layers in the human brain make it
difficult to understand the implication of each cell type
in Alzheimer’s disease. Single-cell RNA-seq is a technology that is maturing rapidly. It is being used to generate
a detailed molecular atlas of the brain and explore ADinduced damage at a cellular level. However, this technology is constrained to the analyses of fresh tissue. Single-nuclei RNA sequencing (snuclRNA-seq) is still in its
initial developmental stages. In this study, we showed
that it is feasible to employ it to ascertain highly informative and unique brain tissue collected during many
years and stored in brain banks. We showed that it is
possible to ascertain a sufficient and diverse number of
transcripts to identify different cell types from three frozen brains from family members with different forms of
Alzheimer’s disease. To our knowledge, this is the first
study to accomplish this.
Using this data, we generated a highly detailed molecular map of human brains for a carrier of a Mendelian mutation in PSEN1 and two sporadic ADs. We
profiled three major groups of cells in the brain, neurons, glial cells (astrocytes, oligodendrocyte, and OPC),
and non-neuronal (endothelial and microglial). Furthermore, we identified distinct types of inhibitory and
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excitatory neurons. To do so, we extended current de
facto methods to correctly process and analyze
snuclRNA-seq data and optimize the number of reads,
genes, and cells available for downstream analyses.
We showed the limitations and biases introduced by alternative approaches, CGS and Hicat Gene Markers,
which were proven to produce reliable results for singlecell RNA-seq. The main problems that we faced were either the uneven representation of subjects in many clusters or clusters with cells that do not show a cell typespecific expression profile. These problems originated
from the approach employed to select the genes to cluster
the nuclei. Although these methods were effective to cluster cells from single-cell RNA sequencing of fresh tissue
or cloned animal models, they were not successful for
snuclRNA-seq data.
Our approach called ConGen is based on the identification of a common set of highly variable genes
in common among the family-related brains. This
allowed us to infer clusters that represent distinct
cell types and subtypes, while providing an approximately even representation of cells from all of the
subjects in the clusters.
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We used this information to analyze the cellular population structure to distinguish structures that are specific to
Mendelian AD and differ from sporadic AD. Our results
showed a reduced percentage of excitatory neurons in the
brain carrier of a PSEN1 mutation in comparison with
two sporadic AD brains. This finding is concordant with
our previous observations that Mendelian AD has distinctive and significantly decreased neuronal cell proportions. This result allows us to hypothesize that this
phenomenon is specific for excitatory neurons in carriers
than sporadic AD, but additional samples should be studied to verify this hypothesis.
We used the microglial cells to study their differential
transcriptomic profiles. To our knowledge, this is the first
attempt to study DAM markers using unsorted
snuclRNA-seq from a PSEN1 p.A79V carrier and related
AD brains. We showed that snuclRNA-seq provides accurate information, but we understand that the limited
number of microglial cells that we sequenced does not
provide enough samples to perform unbiased analyses. In
addition, our pseudo-temporal ordering analyses of pooled
microglia differed from that of donor-specific microglia.
We think that these analyses should be performed in

Fig. 8 Workflow analysis plan. In blue, the single-nuclei data generation. The most important step is the quantification of the nuclei using a “premRNA” annotation. This step will significantly increase the quantity of nuclei and the quantification of their expression profile. In green, the
cleaning and quality control steps. The QC followed standard measurements such as removing mitochondrial genes (MT), removing doublets and
multiples, and the normalization of the data using nUMI, percent mitochondrial reads sample origin as confounding factors. In orange, the
clustering. In this step, we performed the identification of genes that are highly variable in common among brain nuclei from all of the subjects.
Later on, the nuclei can be clustered differently using different resolution, but in general, they are assigned to clusters that are annotated to
group nuclei from the same specific cell type. Next, we identified a hierarchical relationship among the clusters by performing coincidence
analyses. The entropy, from Shannon’s information theory, provides a quantitative measure of even distribution of samples in a cluster. To
annotate the clusters, we use a set of gene markers for each cell type collected from the literature. Finally, a hierarchical clustering of clusters
should reproduce expected results, grouping together neuronal subtypes in one branch and in another branch glial cells
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additional larger datasets. If any difference among donors
is systematically identified, the methods should be extended to correct for any donor-specific effects that might
confound the analyses. Still, our analysis replicated the association of osteopontin (SPI1) with a temporal trajectory.
We believe that by increasing the number of brains and
by sorting the nuclei to capture glial cells, we will provide
the power required to analyze and detect the expression
profile and trajectories of DAM markers in AD brains.
Although all these results are encouraging, we
recognize the limitation posed by the small sample size
as well as these findings are specific to one carrier
PSEN1 p.A79V. In addition, we could not identify any
family-related neuropathology-free sample to employ as
control. While underpowered, it is interesting to note
that some of these results replicate the results of previous studies that were designed to provide sufficient statistical power to comparisons.

Conclusions
Overall, we believe that this work proposes best practices for the generation, processing, and analyses of single-nuclei RNA-seq (Fig. 8) data that maximizes the
amount of information able to be extracted from the
samples. These are the lessons we learned while analyzing these brains: (i) The quantification of the nuclei
using a “pre-mRNA” annotation will significantly increase the quantity of nuclei and the quantification of
their expression profile. (ii) Identification of genes that
are highly variable in common among the brain nuclei
produce clusters with an even representation of all of
the subjects. (iii) Nuclei can be clustered differently
using different resolution, but in general, they are
assigned to clusters that are annotated to the group nuclei from the same specific cell type. In addition, we
identified a hierarchical relationship among the clusters
as a product of different approaches or levels of resolution. To reveal these relationships, we propose coincidence analyses. (iv) Shannon’s information theory of
entropy should be as a quantitative measure of even distribution of all samples in all clusters. (v) To annotate
each cluster, we need to use a consensus set of gene
markers for each cell type from the current literature.
There is not a standard set of gene markers. (vi) A hierarchical clustering of clusters should reproduce expected
results, grouping together neuronal subtypes in one
branch and in another branch glial cells.
Finally, we have generated a highly detailed molecular
atlas of AD brains that we are making available through
an interactive, user-friendly, web-based application. We
believe it will help not only the annotation of other
snuclRNA-seq studies, but also additional high-throughput neurodegenerative genomic studies.
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